rs180690391

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_019066.5(MAGEL2):​c.2692A>G​(p.Ser898Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000936 in 1,613,948 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S898I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0052 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00049 ( 4 hom. )

Consequence

MAGEL2
NM_019066.5 missense

Scores

11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.410

Publications

0 publications found
Variant links:
Genes affected
MAGEL2 (HGNC:6814): (MAGE family member L2) Prader-Willi syndrome (PWS) is caused by the loss of expression of imprinted genes in chromosome 15q11-q13 region. Affected individuals exhibit neonatal hypotonia, developmental delay, and childhood-onset obesity. Necdin (NDN), a gene involved in the terminal differentiation of neurons, localizes to this region of the genome and has been implicated as one of the genes responsible for the etiology of PWS. This gene is structurally similar to NDN, is also localized to the PWS chromosomal region, and is paternally imprinted, suggesting a possible role for it in PWS. [provided by RefSeq, Oct 2010]
MAGEL2 Gene-Disease associations (from GenCC):
  • Schaaf-Yang syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Illumina, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0027456582).
BP6
Variant 15-23645051-T-C is Benign according to our data. Variant chr15-23645051-T-C is described in ClinVar as [Benign]. Clinvar id is 445351.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0052 (792/152372) while in subpopulation AFR AF = 0.0187 (776/41600). AF 95% confidence interval is 0.0176. There are 7 homozygotes in GnomAd4. There are 361 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 792 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAGEL2NM_019066.5 linkc.2692A>G p.Ser898Gly missense_variant Exon 1 of 1 ENST00000650528.1 NP_061939.3 Q9UJ55

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAGEL2ENST00000650528.1 linkc.2692A>G p.Ser898Gly missense_variant Exon 1 of 1 NM_019066.5 ENSP00000497810.1 Q9UJ55

Frequencies

GnomAD3 genomes
AF:
0.00516
AC:
785
AN:
152254
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0185
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000850
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00126
AC:
313
AN:
249324
AF XY:
0.00102
show subpopulations
Gnomad AFR exome
AF:
0.0177
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000885
Gnomad OTH exome
AF:
0.000495
GnomAD4 exome
AF:
0.000492
AC:
719
AN:
1461576
Hom.:
4
Cov.:
32
AF XY:
0.000458
AC XY:
333
AN XY:
727082
show subpopulations
African (AFR)
AF:
0.0178
AC:
597
AN:
33480
American (AMR)
AF:
0.00105
AC:
47
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53268
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000630
AC:
7
AN:
1111868
Other (OTH)
AF:
0.00104
AC:
63
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
52
104
156
208
260
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00520
AC:
792
AN:
152372
Hom.:
7
Cov.:
32
AF XY:
0.00484
AC XY:
361
AN XY:
74516
show subpopulations
African (AFR)
AF:
0.0187
AC:
776
AN:
41600
American (AMR)
AF:
0.000849
AC:
13
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68034
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
41
83
124
166
207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00129
Hom.:
2
Bravo
AF:
0.00557
ESP6500AA
AF:
0.0138
AC:
60
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00156
AC:
189
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Aug 24, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Aug 07, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
2.0
DANN
Benign
0.49
DEOGEN2
Benign
0.051
T;T
FATHMM_MKL
Benign
0.033
N
LIST_S2
Benign
0.26
.;T
MetaRNN
Benign
0.0027
T;T
PhyloP100
-0.41
PrimateAI
Benign
0.25
T
Sift4G
Benign
0.42
T;.
Vest4
0.036
MVP
0.043
MPC
0.060
GERP RS
-1.3
Varity_R
0.030
gMVP
0.048
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs180690391; hg19: chr15-23890198; API